Cargando…

Randomized Crossover Comparison of Injection Site Pain with 40 mg/0.4 or 0.8 mL Formulations of Adalimumab in Patients with Rheumatoid Arthritis

INTRODUCTION: Adalimumab, an anti-tumor necrosis factor antibody, is currently available in a 40 mg/0.8 mL formulation. The objective of this analysis was to evaluate injection site-related pain, safety, and tolerability of a 40 mg/0.4 mL formulation of adalimumab that had fewer excipients, a smalle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nash, Peter, Vanhoof, Johan, Hall, Stephen, Arulmani, Udayasankar, Tarzynski-Potempa, Rita, Unnebrink, Kristina, Payne, Andrew N., Cividino, Alfred
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127965/ https://www.ncbi.nlm.nih.gov/pubmed/27747583 http://dx.doi.org/10.1007/s40744-016-0041-3

Ejemplares similares

Bioavailability study of Enoxaparin Sodium Chemi (80 mg/0.8 mL) and Clexane (80 mg/0.8 mL) subcutaneous injection in healthy adults
por: Febbraro, Salvatore, et al.
Publicado: (2021)

Randomised, phase I pharmacokinetic study of adalimumab biosimilar CT‐P17 (40 mg/0.4 mL) by autoinjector and prefilled syringe in healthy subjects
por: Davidson, Antonia, et al.
Publicado: (2021)

A Randomized Pharmacokinetic Study in Healthy Male Subjects Comparing a High-concentration, Citrate-free SB5 Formulation (40 mg/0.4 ml) and Prior SB5 (Adalimumab Biosimilar)
por: Ahn, So-shin, et al.
Publicado: (2022)

Efficacy of 4.0 mg versus 0.4 mg Folic Acid Supplementation on the Reproductive Outcomes: A Randomized Controlled Trial
por: Bortolus, Renata, et al.
Publicado: (2021)

Tunable Microwave Dielectric Properties of Ca(0.6)La(0.8/3)TiO(3) and Ca(0.8)Sm(0.4/3)TiO(3)-Modified (Mg(0.6)Zn(0.4))(0.95)Ni(0.05)TiO(3) Ceramics with a Near-Zero Temperature Coefficient
por: Pan, Chung-Long, et al.
Publicado: (2021)

Development by Mechanochemistry of La(0.8)Sr(0.2)Ga(0.8)Mg(0.2)O(2.8) Electrolyte for SOFCs
por: Garcia-Garcia, Francisco J., et al.
Publicado: (2020)

Ocular Tolerability of Bimatoprost 0.1 mg/mL Preservative-Free versus Bimatoprost 0.1 mg/mL with Benzalkonium Chloride or Bimatoprost 0.3 mg/mL Preservative-Free in Patients with Primary Open-Angle Glaucoma
por: Filippelli, Mariaelena, et al.
Publicado: (2022)

Effects of Non-Stoichiometry on the Ground State of the Frustrated System Li(0.8)Ni(0.6)Sb(0.4)O(2)
por: Vavilova, Evgeniya, et al.
Publicado: (2021)

Influence of Solution Treatment Time on Precipitation Behavior and Mechanical Properties of Mg-2.0Nd-2.0Sm-0.4Zn-0.4Zr Alloy
por: Ma, Tao, et al.
Publicado: (2021)

The sintering temperature effect on electrochemical properties of Ce(0.8)Sm(0.05)Ca(0.15)O(2-δ) (SCDC)-La(0.6)Sr(0.4)Co(0.2)Fe(0.8)O(3-δ) (LSCF) heterostructure pellet
por: Nie, Xiyu, et al.
Publicado: (2019)

Synthesis, Characterization, and Magnetoresistive Properties of the Epitaxial Pd(0.96)Fe(0.04)/VN/Pd(0.92)Fe(0.08) Superconducting Spin-Valve Heterostructure
por: Yanilkin, Igor, et al.
Publicado: (2020)

Unraveling the Influence of the Electrolyte on the Polarization Resistance of Nanostructured La(0.6)Sr(0.4)Co(0.2)Fe(0.8)O(3-δ) Cathodes
por: Zamudio-García, Javier, et al.
Publicado: (2022)

Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial
por: Burmester, Gerd-Rűdiger, et al.
Publicado: (2015)

Microextrusion Printing of Multilayer Hierarchically Organized Planar Nanostructures Based on NiO, (CeO(2))(0.8)(Sm(2)O(3))(0.2) and La(0.6)Sr(0.4)Co(0.2)Fe(0.8)O(3−δ)
por: Simonenko, Tatiana L., et al.
Publicado: (2022)

Efficiency of 3D‐Ordered Macroporous La(0.6)Sr(0.4)Co(0.2)Fe(0.8)O(3) as an Electrocatalyst for Aprotic Li‐O(2) Batteries
por: Cheng, Junfang, et al.
Publicado: (2019)

Integrated Cr and S poisoning of a La(0.6)Sr(0.4)Co(0.2)Fe(0.8)O(3−δ) (LSCF) cathode for solid oxide fuel cells
por: Wang, Cheng Cheng, et al.
Publicado: (2020)

Investigation of temperature and frequency dependence of the dielectric properties of multiferroic (La(0.8)Ca(0.2))(0.4)Bi(0.6)FeO(3) nanoparticles for energy storage application
por: Bougoffa, Amira, et al.
Publicado: (2022)

CellML 2.0
por: Clerx, Michael, et al.
Publicado: (2020)

The likelihood of having serum level of PSA of ≥4.0 ng/mL and ≥10.0 ng/mL in non-obese and obese Nigerian men with LUTS
por: Adegun, Patrick Temi, et al.
Publicado: (2015)

2375 Pharmacokinetics of phosphatidylethanol 16:0/20:4 homolog in human blood after consumption of 0.4 and 0.8 g/kg alcohol in a laboratory clinical study
por: Lopez-Cruzan, Marisa, et al.
Publicado: (2018)

Efficacy and Tolerability of Tamsulosin 0.4 mg in Patients with Symptomatic Benign Prostatic Hyperplasia
por: Chung, Jae-Wook, et al.
Publicado: (2011)

What is the optimal duration of the TILT after administration of 0.4 mg nitroglycerin spray?
por: Glockler, Antonia, et al.
Publicado: (2020)

Rb/Cs-Modified P2 Na(0.7)Mn(0.8)Mg(0.2)O(2): Application in Sodium-Ion Batteries
por: Sehrawat, Divya, et al.
Publicado: (2019)

Pathological characteristics and predictive factors of prostate biopsy in patients with serum PSA levels between 0 and 4.0 ng/ml
por: Su, Rui, et al.
Publicado: (2022)

The impact of 30 ml/kg hydroxyethyl starch 130/0.4 vs hydroxyethyl starch 130/0.42 on coagulation in patients undergoing abdominal surgery
por: Staikou, Chryssoula, et al.
Publicado: (2012)

Cosmology, Gravity, and the WMAP ratio 0.73:0.23:0.04
por: Smith, F D T
Publicado: (2004)

CellML 2.0.1
por: Clerx, Michael, et al.
Publicado: (2023)

Effect of Isothermal Repetitive Upsetting Extrusion on the Microstructure of Mg-12.0Gd-4.5Y-2.0Zn-0.4Zr Alloy
por: Zhang, Guanshi, et al.
Publicado: (2018)

Comparative Study of the Structure, Properties, and Corrosion Behavior of Sr-Containing Biocoatings on Mg0.8Ca
por: Sedelnikova, Mariya B., et al.
Publicado: (2020)

Field induced crossover in critical behaviour and direct measurement of the magnetocaloric properties of La(0.4)Pr(0.3)Ca(0.1)Sr(0.2)MnO(3)
por: Ghorai, Sagar, et al.
Publicado: (2020)

Evaluation of the pharmacokinetics and food effects of a novel formulation tamsulosin 0.4 mg capsule compared with a 0.2 mg capsule in healthy male volunteers
por: Ban, Mu Seong, et al.
Publicado: (2020)

Investigation on the Selenization Treatment of Kesterite Cu(2)Mg(0.2)Zn(0.8)Sn(S,Se)(4) Films for Solar Cell
por: Jiang, Dongyue, et al.
Publicado: (2019)

Zn–0.8Mg–0.2Sr (wt.%) Absorbable Screws—An In-Vivo Biocompatibility and Degradation Pilot Study on a Rabbit Model
por: Klíma, Karel, et al.
Publicado: (2021)

A detailed mechanism of degradation behaviour of biodegradable as-ECAPed Zn-0.8Mg-0.2Sr with emphasis on localized corrosion attack
por: Pinc, Jan, et al.
Publicado: (2023)

Performance Enhancement of Ce(0.8)Sm(0.2)O(1.9)-Supported SOFC by Electrophoretic Formation of Modifying BaCe(0.8)Sm(0.2)O(3) and Ce(0.8)Sm(0.1)Pr(0.1)O(1.9) Layers
por: Pikalova, Elena, et al.
Publicado: (2023)

A Supernova Search At Z = 0.2 - 0.4
por: Hardin, D
Publicado: (2000)

No differences in metabolic outcomes between nadir GH 0.4 and 1.0 ng/mL during OGTT in surgically cured acromegalic patients (observational study)
por: Ku, Cheol Ryong, et al.
Publicado: (2016)

Dipole Relaxation in Semiconducting Zn(2−x)Mg(x)InV(3)O(11) Materials (Where x = 0.0, 0.4, 1.0, 1.6, and 2.0)
por: Groń, Tadeusz, et al.
Publicado: (2020)

Hydrogen-Tolerant La(0.6)Ca(0.4)Co(0.2)Fe(0.8)O(3–d) Oxygen Transport Membranes from Ultrasonic Spray Synthesis for Plasma-Assisted CO(2) Conversion
por: Rashid, Aasir, et al.
Publicado: (2023)

Analysis of nanofiber-based La(0.2)Sr(0.8)TiO(3)–Gd(0.2)Ce(0.8)O(1.9) electrode kinetics
por: Wang, Yuwei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l9eqnptrl4ibeftafqkabrfg7b